Drugs / Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Pichia pastoris)
Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Pichia pastoris)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04965350 | Apr 2021 → Apr 2022 | human papilloma virus infection | Shanghai Zerun Biotechnology Co.,Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Pichia pastoris) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04965350 ↗ |
| Modality | Vaccine | “bivalent HPV vaccine” NCT04965350 ↗ |
| Route | Intramuscular | “sterile solution for intramuscular injection” NCT04965350 ↗ |